Nabriva Therapeutics plc Common Stock, Value, Issued
Nabriva Therapeutics plc had Common Stock, Value, Issued of $32.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2023-10-19
- 2023-06-30: Common Stock, Value, Issued $32.00K.
- 2023-03-31: Common Stock, Value, Issued $32.00K.
- 2022-12-31: Common Stock, Value, Issued $32.00K.
- 2022-09-30: Common Stock, Value, Issued $30.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2023-06-30 | $32.00K 10-Q · filed 2023-10-19 | |
| 2023-03-31 | $32.00K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $32.00K 10-Q · filed 2023-10-19 | |
| 2022-09-30 | $30.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $646.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $617.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $23.00K 10-K · filed 2023-04-17 | $567.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $543.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $497.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $354.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $211.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.50M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.43M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $951.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $95.00K 10-K · filed 2021-03-11 | $945.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | $780.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $729.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $713.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $670.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $665.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $410.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $402.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $367.00K 10-K · filed 2019-03-12 | |
| 2017-03-31 | $2.95M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.94M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $2.41M 10-K · filed 2017-03-24 |